BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6537452)

  • 1. [Uremic toxins. Chromatographic profiles of substances of low and medium molecular weight].
    Nesse AB; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(2):117-26. PubMed ID: 6537452
    [No Abstract]   [Full Text] [Related]  

  • 2. [Uremic toxins. Mechanisms of excretion, diffusibility through membranes and rate of storage].
    Nesse AB; Arrizurieta de Muchnik E
    Medicina (B Aires); 1984; 44(2):127-36. PubMed ID: 6537453
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal handling of middle molecules in uremic patients and in the isolated rat kidney.
    Lustenberger N; Schindhelm K; Nordmeyer C; Schurek HJ; Stolte H
    Artif Organs; 1981; 4 Suppl():110-4. PubMed ID: 7295076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The factors that determine the manifestation of uremic poisoning during the development of chronic kidney failure].
    Rumiantsev ASh; Panina IIu; Kozlov VV; Lukichev BG; Tsiura VI; Kaznacheeva IG; Abdiadilova LV
    Ter Arkh; 1991; 63(6):71-4. PubMed ID: 1948753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal strategies for the removal of middle molecules.
    Winchester JF; Audia PF
    Semin Dial; 2006; 19(2):110-4. PubMed ID: 16551287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a 1100-1300 MW uremic neurotoxin.
    Funck-Brentano JL; Man NK; Sausse A; Zingraff J; Boudet J; Becker A; Cueille GF
    Trans Am Soc Artif Intern Organs; 1976; 22():163-7. PubMed ID: 951836
    [No Abstract]   [Full Text] [Related]  

  • 8. Uremic toxins: a new focus on an old subject.
    Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
    Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
    Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
    Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic value of middle molecule clearance in acute inflammatory organic diseases of the urogenital system].
    Dolgin MR; Slutskin IM; Levitskiĭ ER; Gabriélian NI; Poddubnaia LP
    Urol Nefrol (Mosk); 1987; (4):17-20. PubMed ID: 3660506
    [No Abstract]   [Full Text] [Related]  

  • 11. Middle molecules in uraemia.
    Fürst P; Asaba M; Gordon A; Zimmerman L; Bergström J
    Proc Eur Dial Transplant Assoc; 1975; 11():417-26. PubMed ID: 1105558
    [No Abstract]   [Full Text] [Related]  

  • 12. Mass spectrometry in the search for uremic toxins.
    Niwa T
    Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inorganic sulphates in relation to the serum thyroxine level and in renal failure.
    Tallgren LG
    Acta Med Scand Suppl; 1980; 640():1-100. PubMed ID: 6932170
    [No Abstract]   [Full Text] [Related]  

  • 14. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Middle molecules--a marker of endogenous intoxication (a review of the literature)].
    Parfenkova GA; Cherniad'eva IF; Sitina VK
    Vrach Delo; 1987 Apr; (4):72-7. PubMed ID: 3303687
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood and urinary middle molecules in the diagnosis of inflammatory urological diseases and chronic kidney failure and the evaluation of plasmapheresis effectiveness].
    Kozlov VA; Chudnovskaia MV; Danilkov AP; Solov'ev NK
    Urol Nefrol (Mosk); 1987; (4):12-7. PubMed ID: 3660505
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent progress in the analysis of uremic toxins by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2600-6. PubMed ID: 19083276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypermagnesemia].
    Fiedorczuk Z; Pelka W
    Wiad Lek; 1972 Jul; 25(12):1073-6. PubMed ID: 4558214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolic anomaly and uremic toxins in chronic renal insufficiency].
    Ueda Y
    Nihon Rinsho; 1974 Mar; 32(3):446-8. PubMed ID: 4859022
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.